Form 8.3

Key Information - Rathbones Group Plc disclosed a position in Life Science REIT Plc, holding 10,607,078 relevant securities, representing 3.0306% of the total [1][3] - The position was disclosed as of January 30, 2026, with the disclosure made on February 2, 2026 [1][14] - The discloser is also making disclosures regarding other parties involved in the offer [1] Positions - The interests held by Rathbones Group Plc include 10,607,078 ordinary shares, which accounts for 3.0306% of the relevant securities [3] Dealings - Rathbones Group Plc executed multiple sales of 1p Ordinary Shares at prices ranging from 42.6p to 42.6756p, with a total of 12,316,042 shares sold at a unit price of 42.623152p [7] - The total number of shares sold includes various transactions, with the largest single sale being 12,316,042 shares [7] Other Information - There are no indemnity or other dealing arrangements related to the relevant securities disclosed by Rathbones Group Plc [12] - No agreements or understandings regarding voting rights or future acquisition or disposal of relevant securities have been reported [13]